glp-1 and gip dual agonist Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care Dual GLP-1/GIP Agonist | Tirzepatide

Maybe, but you might not as well

Notably, epidemiological data indicate that Asian populations develop diabetes at a significantly younger age than White populations, exhibiting elevated risks of disease-related complications and mortality, thereby imposing a considerable healthcare burden [117]

Jacobsen L, Hindsberger C, Robson R, et al

Brain imaging studies have found similar changes in dopamine receptors, the neurotransmitter that creates a feeling of well-being and motivates us to repeat behaviors in people who overeat and use alcohol and drugs

3 Department of Physical Chemistry and Technology of Polymers, Silesian University of Technology, Gliwice, Poland